Industry
Zydus’ generic of hormone therapy patch gets U.S. FDA nod
The Hindu - Industry·21 Oct 2026
The product is eligible for the 180-day exclusivity period available to certain first approved applicants under the CGT pathway, subject to the provisions of the U.S. Federal Food, Drug, and Cosmetic…
More news in Industry
India is a highly fragmented media viewing market, says U.S. audience measurement firm Nielsen
NHAI turns to AI and open source to preserve institutional knowledge lost to officer transfers
After Amazon, Google targets Nvidia’s software lock-in with TorchTPU
Jio Platforms' IPO fully subscribed in 100 minutes of opening, marks fastest-ever subscribed offer
Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer
NHAI turns to AI and open source to preserve institutional knowledge lost to officer transfersAfter Amazon, Google targets Nvidia’s software lock-in with TorchTPUJio Platforms' IPO fully subscribed in 100 minutes of opening, marks fastest-ever subscribed offerDr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer